miR-455-3p is Involved in the Pathological Mechanism of Pulpitis by Modulating ACTG1

Yuejing Xu1, Yihan Fu2, Lei Zhang3

  • 1Department of Stomatology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

PubMed
Abstract

Insights

MicroRNA-455-3p (miR-455-3p) is a potential diagnostic biomarker for pulpitis. This study found that miR-455-3p enhances cell proliferation and inhibits apoptosis by regulating ACTG1, offering insights into pulpitis mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Dental Research

Background:

  • Pulpitis, an inflammatory condition caused by bacteria, leads to severe pain and reduced quality of life.
  • MicroRNA-455-3p (miR-455-3p) is implicated in various diseases, but its role in pulpitis remains unclear.

Purpose of the Study:

  • To identify a novel biomarker for pulpitis diagnosis.
  • To elucidate the molecular mechanisms underlying pulpitis involving miR-455-3p.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure miR-455-3p and ACTG1 levels.
  • Dual-luciferase reporter assay to confirm targeting.
  • Cell Counting Kit-8 (CCK-8) assay for proliferation analysis.
  • Flow cytometry for apoptosis assessment.

Main Results:

  • miR-455-3p levels were significantly decreased in pulpitis patients' serum and tissues.
  • ROC curve analysis indicated good diagnostic performance for miR-455-3p in pulpitis.
  • In vitro studies showed miR-455-3p levels inversely correlated with LPS concentration and treatment time, with LPS suppressing proliferation.
  • Upregulated miR-455-3p promoted proliferation and inhibited apoptosis, while downregulated miR-455-3p had opposite effects.
  • ACTG1 was identified as a direct target of miR-455-3p, negatively regulated by it. Upregulating miR-455-3p counteracted LPS-induced effects, an effect reversed by ACTG1 overexpression.

Conclusions:

  • miR-455-3p shows promise as a novel diagnostic biomarker for pulpitis.
  • miR-455-3p enhances proliferation and suppresses apoptosis in pulpitis by negatively regulating ACTG1.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...